Benign Prostatic Hypertrophy
Also known as: Prostatic Hypertrophy, Benign / Benign Prostatic Hypertrophy (BPH) / BPH / Prostatic hypertrophy (benign) / Enlarged prostate (benign) / Benign prostatic hyperplasia / Benign prostatic hyperplasia (disorder) / Prostatic hypertrophy
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB00706 | Tamsulosin | An alpha-1A and alpha-1B adrenergic receptor antagonist used to treat benign prostatic hyperplasia, ureteral stones, prostatitis, and female voiding dysfunction. |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00820 | Tadalafil | 1 | Completed | 1 |
| DB00706 | Tamsulosin | 1 | Completed | 1 |
| DB00898 | Ethanol | 1 / 2 | Completed | 1 |
| DB06699 | Degarelix | 2 | Completed | 1 |
| DB11231 | Lycopene | 2 | Completed | 1 |
| DB08893 | Mirabegron | 2 | Unknown Status | 1 |
| DB12581 | Ozarelix | 2 | Completed | 1 |
| DB01229 | Paclitaxel | 2 | Active Not Recruiting | 1 |
| DB00706 | Tamsulosin | 2 | Not Yet Recruiting | 1 |
| DB00862 | Vardenafil | 2 | Completed | 1 |
| DB00346 | Alfuzosin | 3 | Completed | 1 |
| DB00050 | Cetrorelix | 3 | Completed | 2 |
| DB00050 | Cetrorelix | 3 | Terminated | 1 |
| DB00590 | Doxazosin | 3 | Completed | 1 |
| DB01216 | Finasteride | 3 | Completed | 1 |
| DB00695 | Furosemide | 3 | Recruiting | 1 |
| DB05493 | NX-1207 | 3 | Completed | 1 |
| DB00346 | Alfuzosin | 4 | Completed | 1 |
| DB01028 | Methoxyflurane | 4 | Completed | 1 |
| DB06207 | Silodosin | 4 | Completed | 1 |
| DB01591 | Solifenacin | 4 | Completed | 1 |
| DB00820 | Tadalafil | 4 | Completed | 1 |
| DB00706 | Tamsulosin | 4 | Completed | 2 |
| DB00706 | Tamsulosin | 4 | Recruiting | 1 |
| DB00302 | Tranexamic acid | 4 | Active Not Recruiting | 1 |
| DB00346 | Alfuzosin | Not Available | Completed | 1 |
| DB00083 | Botulinum toxin type A | Not Available | Not Yet Recruiting | 1 |
| DB01126 | Dutasteride | Not Available | Completed | 1 |
| DB00898 | Ethanol | Not Available | Completed | 1 |